Ofer Haviv

Cannabis company Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) announced its second quarter financial results on Thursday for the period ended June 30, 2023, revealing a significant year-over-year uptick in revenue to roughly $654 000 compared to approximately $312 000 in the same period the...

Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) released its financial results for the first quarter period ending March 31, 2023, revealing revenues of $641,000, an increase of 170% compared to $237,000 in the same period the previous year. The revenue increase was primarily due to revenues recognized per...

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) Q2 2022 revenue was $312,000, an increase of 131% compared to $135,000 in the same period the previous year. Revenues were primarily due to the initial sales of Lavie Bio's Thrivus product (previously branded as Result) and sales of Canonic products in...

Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) released its financial results for the first quarter ended March 31, 2022, revealing revenue of $237,000 in comparison to $333,000 in the same period the previous year. Q1 Financial Highlights The net loss for the quarter was $9.1 million in comparison to $...

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) announced its financial results for the fourth quarter and full year of 2021, ended December 31, 2021. Q4 Financial Highlights Consolidated cash usage was approximately $8.4 million, or $7 million, excluding Lavie Bio compared to roughly $6.1 million, or $5...

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), the parent company of medical cannabis-focused Canonic, reported its financial results Wednesday for the first nine months and third quarter of 2021. The Israel-based company maintained a strong financial position for its activities with $61.6...

Biotechnology company Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) posted its financial results Wednesday for the first half and second quarter of 2021 along with a proclamation from the company's president and CEO Ofer Haviv in which he said that this fiscal year is “turning out to be a...